APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metoclopramide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metoclopramide Tablets Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchMetoclopramide Tablets Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Metoclopramide Tablets Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Metoclopramide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metoclopramide Tablets Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Metoclopramide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Metoclopramide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metoclopramide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metoclopramide Tablets include Yabao Pharmaceutical Group Co., Ltd., Xi'an Fenghua Pharmaceutical Co., Ltd., Tianjin Lisheng Pharmaceutical Co., Ltd., Taosheng Pharmaceutical Co., Ltd., Shijiazhuang Dongfang Pharmaceutical Co., Ltd., Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Shanxi Guorun Pharmaceutical Co., Ltd. and Shandong Xinhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metoclopramide Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metoclopramide Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metoclopramide Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metoclopramide Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metoclopramide Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metoclopramide Tablets Market by Company

Yabao Pharmaceutical Group Co., Ltd.

Xi'an Fenghua Pharmaceutical Co., Ltd.

Tianjin Lisheng Pharmaceutical Co., Ltd.

Taosheng Pharmaceutical Co., Ltd.

Shijiazhuang Dongfang Pharmaceutical Co., Ltd.

Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shanxi Guorun Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Liaoning Ludan Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Jinan Hengji Pharmaceutical Co., Ltd.

Jilin Jinheng Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

Sinopharm Group Guorui Pharmaceutical Co., Ltd.

Beijing Zhongxin Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Anhui Huachen Pharmaceutical Co., Ltd.

Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.

Metoclopramide Tablets Segment by Type

5mg

10mg

Metoclopramide Tablets Segment by Application

Online e-commerce

Pharmacy

Hospital

Other

Metoclopramide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metoclopramide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metoclopramide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metoclopramide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metoclopramide Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metoclopramide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5mg Table 2. Major Company of 10mg Table 3. Global Metoclopramide Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Metoclopramide Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Metoclopramide Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Metoclopramide Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Metoclopramide Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Metoclopramide Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Metoclopramide Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Metoclopramide Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Metoclopramide Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Metoclopramide Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Metoclopramide Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Metoclopramide Tablets Industry Trends Table 25. Metoclopramide Tablets Industry Drivers Table 26. Metoclopramide Tablets Industry Opportunities and Challenges Table 27. Metoclopramide Tablets Industry Restraints Table 28. Global Metoclopramide Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Metoclopramide Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Metoclopramide Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Metoclopramide Tablets Sales Share by Company (2021-2026) Table 32. Global Metoclopramide Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Metoclopramide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Metoclopramide Tablets Major Company Production Sites and Headquarters Table 35. Global Metoclopramide Tablets Company, Product Type & Application Table 36. Global Metoclopramide Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Metoclopramide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Metoclopramide Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Metoclopramide Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Metoclopramide Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Metoclopramide Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Metoclopramide Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Metoclopramide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Metoclopramide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Metoclopramide Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Metoclopramide Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Metoclopramide Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Metoclopramide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Metoclopramide Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Metoclopramide Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Metoclopramide Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Metoclopramide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Metoclopramide Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Metoclopramide Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Metoclopramide Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Metoclopramide Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Metoclopramide Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Metoclopramide Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Metoclopramide Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 72. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 73. Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Product Portfolio Table 75. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 76. Xi'an Fenghua Pharmaceutical Co., Ltd. Company Information Table 77. Xi'an Fenghua Pharmaceutical Co., Ltd. Business Overview Table 78. Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 80. Xi'an Fenghua Pharmaceutical Co., Ltd. Recent Development Table 81. Tianjin Lisheng Pharmaceutical Co., Ltd. Company Information Table 82. Tianjin Lisheng Pharmaceutical Co., Ltd. Business Overview Table 83. Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 85. Tianjin Lisheng Pharmaceutical Co., Ltd. Recent Development Table 86. Taosheng Pharmaceutical Co., Ltd. Company Information Table 87. Taosheng Pharmaceutical Co., Ltd. Business Overview Table 88. Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 90. Taosheng Pharmaceutical Co., Ltd. Recent Development Table 91. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information Table 92. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview Table 93. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 95. Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Development Table 96. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Company Information Table 97. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Business Overview Table 98. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 100. Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Recent Development Table 101. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 102. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 103. Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 105. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Development Table 106. Shanxi Guorun Pharmaceutical Co., Ltd. Company Information Table 107. Shanxi Guorun Pharmaceutical Co., Ltd. Business Overview Table 108. Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 110. Shanxi Guorun Pharmaceutical Co., Ltd. Recent Development Table 111. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 112. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 113. Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 115. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 116. Liaoning Ludan Pharmaceutical Co., Ltd. Company Information Table 117. Liaoning Ludan Pharmaceutical Co., Ltd. Business Overview Table 118. Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 120. Liaoning Ludan Pharmaceutical Co., Ltd. Recent Development Table 121. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 122. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 123. Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 125. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 126. Jinan Hengji Pharmaceutical Co., Ltd. Company Information Table 127. Jinan Hengji Pharmaceutical Co., Ltd. Business Overview Table 128. Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 130. Jinan Hengji Pharmaceutical Co., Ltd. Recent Development Table 131. Jilin Jinheng Pharmaceutical Co., Ltd. Company Information Table 132. Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview Table 133. Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 135. Jilin Jinheng Pharmaceutical Co., Ltd. Recent Development Table 136. Henan Runhong Pharmaceutical Co., Ltd. Company Information Table 137. Henan Runhong Pharmaceutical Co., Ltd. Business Overview Table 138. Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 140. Henan Runhong Pharmaceutical Co., Ltd. Recent Development Table 141. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Company Information Table 142. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Business Overview Table 143. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 145. Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Development Table 146. Beijing Zhongxin Pharmaceutical Co., Ltd. Company Information Table 147. Beijing Zhongxin Pharmaceutical Co., Ltd. Business Overview Table 148. Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 150. Beijing Zhongxin Pharmaceutical Co., Ltd. Recent Development Table 151. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 152. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 153. Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 155. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 156. Anhui Huachen Pharmaceutical Co., Ltd. Company Information Table 157. Anhui Huachen Pharmaceutical Co., Ltd. Business Overview Table 158. Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 160. Anhui Huachen Pharmaceutical Co., Ltd. Recent Development Table 161. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Company Information Table 162. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Business Overview Table 163. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio Table 165. Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Recent Development Table 166. North America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 168. North America Metoclopramide Tablets Sales Market Share by Country (2021-2026) Table 169. North America Metoclopramide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Metoclopramide Tablets Sales Market Share Forecast by Country (2027-2032) Table 171. North America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Metoclopramide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Metoclopramide Tablets Market Share by Country (2021-2026) Table 174. North America Metoclopramide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Metoclopramide Tablets Market Share Forecast by Country (2027-2032) Table 176. Europe Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 178. Europe Metoclopramide Tablets Sales Market Share by Country (2021-2026) Table 179. Europe Metoclopramide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Metoclopramide Tablets Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Metoclopramide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Metoclopramide Tablets Market Share by Country (2021-2026) Table 184. Europe Metoclopramide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Metoclopramide Tablets Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Metoclopramide Tablets Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Metoclopramide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Metoclopramide Tablets Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Metoclopramide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Metoclopramide Tablets Market Share by Country (2021-2026) Table 194. Asia-Pacific Metoclopramide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Metoclopramide Tablets Market Share Forecast by Country (2027-2032) Table 196. Latin America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 198. Latin America Metoclopramide Tablets Sales Market Share by Country (2021-2026) Table 199. Latin America Metoclopramide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Metoclopramide Tablets Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Metoclopramide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Metoclopramide Tablets Market Share by Country (2021-2026) Table 204. Latin America Metoclopramide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Metoclopramide Tablets Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Metoclopramide Tablets Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Metoclopramide Tablets Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Metoclopramide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Metoclopramide Tablets Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Metoclopramide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Metoclopramide Tablets Market Share by Country (2021-2026) Table 214. Middle East and Africa Metoclopramide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Metoclopramide Tablets Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Metoclopramide Tablets Distributors List Table 219. Metoclopramide Tablets Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Metoclopramide Tablets Image Figure 2. Global Metoclopramide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metoclopramide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Metoclopramide Tablets Sales (2021-2032) & (K Units) Figure 5. 5mg Image Figure 6. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10mg Image Figure 8. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Metoclopramide Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Metoclopramide Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Metoclopramide Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Metoclopramide Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Metoclopramide Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Metoclopramide Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Metoclopramide Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Metoclopramide Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Metoclopramide Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Metoclopramide Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Metoclopramide Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Metoclopramide Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Metoclopramide Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online e-commerce Image Figure 24. Global Online e-commerce Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Metoclopramide Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Metoclopramide Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Metoclopramide Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Metoclopramide Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Metoclopramide Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Metoclopramide Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Metoclopramide Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Metoclopramide Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Metoclopramide Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Metoclopramide Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Metoclopramide Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Metoclopramide Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Metoclopramide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Metoclopramide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Metoclopramide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Metoclopramide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metoclopramide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Metoclopramide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Metoclopramide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Metoclopramide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metoclopramide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Metoclopramide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Metoclopramide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Metoclopramide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metoclopramide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Metoclopramide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Metoclopramide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Metoclopramide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metoclopramide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Metoclopramide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Metoclopramide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Metoclopramide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Metoclopramide Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Metoclopramide Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Online e-commerce
  • Pharmacy
  • Hospital
  • Other
Companies covered
  • Yabao Pharmaceutical Group Co., Ltd.
  • Xi'an Fenghua Pharmaceutical Co., Ltd.
  • Tianjin Lisheng Pharmaceutical Co., Ltd.
  • Taosheng Pharmaceutical Co., Ltd.
  • Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
  • Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shanxi Guorun Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Liaoning Ludan Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Jinan Hengji Pharmaceutical Co., Ltd.
  • Jilin Jinheng Pharmaceutical Co., Ltd.
  • Henan Runhong Pharmaceutical Co., Ltd.
  • Sinopharm Group Guorui Pharmaceutical Co., Ltd.
  • Beijing Zhongxin Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Anhui Huachen Pharmaceutical Co., Ltd.
  • Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metoclopramide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metoclopramide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metoclopramide Tablets Market by Type
  6. 1.3.1 5mg
  7. 1.3.2 10mg
  8. 1.4 Global Metoclopramide Tablets Market Size by Type
  9. 1.4.1 Global Metoclopramide Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Metoclopramide Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Metoclopramide Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Metoclopramide Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Metoclopramide Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Metoclopramide Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Metoclopramide Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Metoclopramide Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metoclopramide Tablets Industry Trends
  2. 2.2 Metoclopramide Tablets Industry Drivers
  3. 2.3 Metoclopramide Tablets Industry Opportunities and Challenges
  4. 2.4 Metoclopramide Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metoclopramide Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Metoclopramide Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Metoclopramide Tablets Price (2021-2026)
  4. 3.4 Global Metoclopramide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metoclopramide Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Metoclopramide Tablets Company, Product Type & Application
  7. 3.7 Global Metoclopramide Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metoclopramide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metoclopramide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metoclopramide Tablets Tier 1, Tier 2, and Tier 3
4 Metoclopramide Tablets Regional Status and Outlook
  1. 4.1 Global Metoclopramide Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metoclopramide Tablets Historic Market Size by Region
  3. 4.2.1 Global Metoclopramide Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metoclopramide Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metoclopramide Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metoclopramide Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Metoclopramide Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metoclopramide Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metoclopramide Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metoclopramide Tablets by Application
  1. 5.1 Metoclopramide Tablets Market by Application
  2. 5.1.1 Online e-commerce
  3. 5.1.2 Pharmacy
  4. 5.1.3 Hospital
  5. 5.1.4 Other
  6. 5.2 Global Metoclopramide Tablets Market Size by Application
  7. 5.2.1 Global Metoclopramide Tablets Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Metoclopramide Tablets Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Metoclopramide Tablets Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Metoclopramide Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Metoclopramide Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Metoclopramide Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Metoclopramide Tablets Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Metoclopramide Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yabao Pharmaceutical Group Co., Ltd.
  2. 6.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  3. 6.1.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  4. 6.1.3 Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yabao Pharmaceutical Group Co., Ltd. Metoclopramide Tablets Product Portfolio
  6. 6.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  7. 6.2 Xi'an Fenghua Pharmaceutical Co., Ltd.
  8. 6.2.1 Xi'an Fenghua Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Xi'an Fenghua Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xi'an Fenghua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  12. 6.2.5 Xi'an Fenghua Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Tianjin Lisheng Pharmaceutical Co., Ltd.
  14. 6.3.1 Tianjin Lisheng Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Tianjin Lisheng Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tianjin Lisheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  18. 6.3.5 Tianjin Lisheng Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Taosheng Pharmaceutical Co., Ltd.
  20. 6.4.1 Taosheng Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Taosheng Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Taosheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  24. 6.4.5 Taosheng Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
  26. 6.5.1 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  30. 6.5.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd.
  32. 6.6.1 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  36. 6.6.5 Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  38. 6.7.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  42. 6.7.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shanxi Guorun Pharmaceutical Co., Ltd.
  44. 6.8.1 Shanxi Guorun Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shanxi Guorun Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanxi Guorun Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  48. 6.8.5 Shanxi Guorun Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Shandong Xinhua Pharmaceutical Co., Ltd.
  50. 6.9.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shandong Xinhua Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  54. 6.9.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Liaoning Ludan Pharmaceutical Co., Ltd.
  56. 6.10.1 Liaoning Ludan Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Liaoning Ludan Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Liaoning Ludan Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  60. 6.10.5 Liaoning Ludan Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Jiangsu Jibei Pharmaceutical Co., Ltd.
  62. 6.11.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  66. 6.11.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Jinan Hengji Pharmaceutical Co., Ltd.
  68. 6.12.1 Jinan Hengji Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Jinan Hengji Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jinan Hengji Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  72. 6.12.5 Jinan Hengji Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jilin Jinheng Pharmaceutical Co., Ltd.
  74. 6.13.1 Jilin Jinheng Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jilin Jinheng Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  78. 6.13.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Henan Runhong Pharmaceutical Co., Ltd.
  80. 6.14.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Henan Runhong Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  84. 6.14.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
  86. 6.15.1 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  90. 6.15.5 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Beijing Zhongxin Pharmaceutical Co., Ltd.
  92. 6.16.1 Beijing Zhongxin Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Beijing Zhongxin Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Beijing Zhongxin Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  96. 6.16.5 Beijing Zhongxin Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  102. 6.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Anhui Huachen Pharmaceutical Co., Ltd.
  104. 6.18.1 Anhui Huachen Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Anhui Huachen Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Anhui Huachen Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  108. 6.18.5 Anhui Huachen Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd.
  110. 6.19.1 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Metoclopramide Tablets Product Portfolio
  114. 6.19.5 Anhui Dongsheng Youbang Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Metoclopramide Tablets Sales by Country
  2. 7.1.1 North America Metoclopramide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metoclopramide Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Metoclopramide Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metoclopramide Tablets Market Size by Country
  6. 7.2.1 North America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metoclopramide Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Metoclopramide Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metoclopramide Tablets Sales by Country
  2. 8.1.1 Europe Metoclopramide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metoclopramide Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Metoclopramide Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metoclopramide Tablets Market Size by Country
  6. 8.2.1 Europe Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metoclopramide Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metoclopramide Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metoclopramide Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Metoclopramide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metoclopramide Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metoclopramide Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metoclopramide Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metoclopramide Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metoclopramide Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metoclopramide Tablets Sales by Country
  2. 10.1.1 South America Metoclopramide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metoclopramide Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Metoclopramide Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metoclopramide Tablets Market Size by Country
  6. 10.2.1 South America Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metoclopramide Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Metoclopramide Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metoclopramide Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Metoclopramide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metoclopramide Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metoclopramide Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metoclopramide Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Metoclopramide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metoclopramide Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metoclopramide Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metoclopramide Tablets Value Chain Analysis
  2. 12.1.1 Metoclopramide Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metoclopramide Tablets Production Mode & Process
  7. 12.2 Metoclopramide Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metoclopramide Tablets Distributors
  10. 12.2.3 Metoclopramide Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst